Correction: Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study) Authors: Meagan Mooney, Charlene Weight, Mia J Biondi, Jason Grebely, Nadine Kronfli, Tamara Barnett, Julie Bruneau, Kate Dunn, Daniel N Elakpa, Cole Etherington, Christina Greenaway, Valérie Martel-Laferrière, Andrew Mendlowitz, Natalie Taylor, Guillaume Fontaine Published: 2026 Correction: Implementation Science Communications (2025) 7:10 10.1186/s43058-025-00837-3 In this article the Competing interests statement was incorrectly given as NK reports investigator-initiated studies from ViiV Healthcare, Abbvie, and Gilead, and honoraria from Abbvie, all outside this work. JB reports investigator-initiated studies from Gilead, and honoraria from Gilead and Abbvie, all outside this work. JG has received research grants, speaker fees, and participated on advisory boards for AbbVie, Abbott, bioLytical, Cepheid, Gilead Sciences, Hologic, and Roche. GF reports speaker fees/hospitality from Gilead and Abbvie, all outside this work but should have been NK reports investigator-initiated studies from ViiV Healthcare, Abbvie, and Gilead, and honoraria from Abbvie, all outside this work. JB reports investigator-initiated studies from Gilead, and honoraria from Gilead and Abbvie, all outside this work. JG has received research grants, speaker fees, and participated on advisory boards for AbbVie, Abbott, bioLytical, Cepheid, Gilead Sciences, Hologic, and Roche. GF reports speaker fees/hospitality from Gilead and Abbvie, all outside this work and is an Associate Editor of Implementation Science Communications. The original article has been corrected. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.